+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Injections for SMA Market - Global Forecast 2025-2030- Product Image
Injections for SMA Market - Global Forecast 2025-2030- Product Image
Sale

Injections for SMA Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6118347
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Spinal Muscular Atrophy injection therapeutics represent a highly dynamic market shaped by ongoing scientific, regulatory, and commercial advances. Senior leaders need a concise, reliable overview to confidently devise growth strategies and maintain a competitive edge in this evolving sector.

Market Snapshot: Spinal Muscular Atrophy Injection Therapeutics

The global market for Spinal Muscular Atrophy (SMA) injection therapeutics is advancing rapidly, driven by the integration of antisense oligonucleotide and gene therapy platforms, robust R&D investment, and expanding regulatory clarity. These therapies are redefining treatment for this genetic neuromuscular disorder, offering significant clinical benefits and fundamentally shifting standard care pathways. Notably, enhanced delivery technologies and streamlined approval processes are improving patient access, while the market addresses diverse geographic and payer requirements. This landscape demands informed decision-making as new players, innovative technologies, and operational complexities reshape growth opportunities.

Scope & Segmentation

The report provides an in-depth review and forecast of the SMA injection therapeutics market across multiple, strategically relevant segments:

  • Mechanism of Action:
    • Antisense Oligonucleotide Therapy
    • Gene Therapy
  • Route of Administration:
    • Intrathecal Injection
    • Intravenous Injection
  • Indication:
    • Type I
    • Type II
    • Type III
    • Type IV
  • End User:
    • Clinics
    • Ambulatory Clinics
    • Specialty Clinics
    • Homecare Settings
    • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Distribution Channel:
    • Hospital Pharmacy
    • Contract Pharmacy
    • In-House Pharmacy
    • Retail Pharmacy
    • Chain Pharmacy
    • Independent Pharmacy
    • Online Pharmacy
    • Specialty Pharmacy
  • Geographical Coverage:
    • Americas (including United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina)
    • Europe, Middle East & Africa (spanning United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland)
    • Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Company Coverage:
    • Biogen Inc.
    • Novartis Gene Therapies, Inc.
    • Ionis Pharmaceuticals, Inc.

Key Takeaways

  • Regulatory authorities have introduced pathways such as conditional approvals and adaptive licensing, accelerating the introduction of innovative SMA injection therapies while enabling real-world evidence collection.
  • The emergence of antisense oligonucleotide and gene therapy modalities is driving diversification in treatment strategies; organizations must address differences in delivery requirements, safety, and durability.
  • Sophisticated cold-chain logistics and scalable manufacturing solutions are playing a crucial role in maintaining product integrity and rapid response to market demand.
  • Segmentation by route of administration and end users enables tailored clinical development and commercialization—supporting optimal uptake among clinics, hospitals, and home-based care networks.
  • Strategic alliances, including partnerships with contract development and manufacturing organizations, are enabling agile market entry and mitigating risks associated with scale-up.
  • Expanding digital health integration is supporting monitoring, education, and adherence, reinforcing value for stakeholders across the care continuum.

Tariff Impact on SMA Injection Supply Chains

Forthcoming changes in United States tariff policy are expected to increase costs for raw materials and finished biologics integral to SMA injections. Elevated duties may create new obstacles in importing active ingredients and consumables, leading manufacturers to reassess the resiliency of their supply chains and explore alternative sourcing, localized production, and proactive engagement with trade authorities. These policy adjustments heighten the need for contingency planning in procurement, pricing, and reimbursement negotiations.

Methodology & Data Sources

This executive analysis is grounded in extensive secondary research from peer-reviewed journals, regulatory filings, industry publications, and scientific conference material. Key findings were validated through interviews with opinion leaders and industry executives across multiple regions, supported by rigorous data modeling and peer-reviewed segmentation frameworks.

Why This Report Matters for Decision-Makers

  • Streamline market entry and expansion by understanding regulatory, clinical, and payer dynamics tailored to each major region.
  • Inform strategic planning and resource allocation using actionable segmentation analysis and robust supply chain insights.
  • Mitigate market uncertainty by leveraging comprehensive competitive intelligence, tariff impact assessment, and emerging technology trends.

Conclusion

SMA injection therapeutics are poised for ongoing evolution, propelled by innovative therapies and adaptive market frameworks. Leaders equipped with these insights can confidently navigate complexity, fostering long-term growth and sustainable patient impact.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. FDA approval of novel gene therapy injection Zolgensma and its market expansion strategies in emerging markets
5.2. Advances in intrathecal antisense oligonucleotide design improving delivery and durability for SMA patients
5.3. Payment and reimbursement models adapting to high-cost SMA injection therapies across major healthcare systems
5.4. Real-world evidence studies demonstrating long-term efficacy and safety of new SMA gene therapy injections
5.5. Emerging biomarkers guiding personalized dosing regimens for antisense injections in SMA type 1 and 2
5.6. Competitive dynamics between Biogen’s Spinraza and emerging gene therapies in the SMA treatment landscape
5.7. Manufacturing scale-up challenges and partnerships driving cost efficiencies in SMA injection production
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Injections for SMA Market, by Mechanism Of Action
8.1. Introduction
8.2. Antisense Oligonucleotide Therapy
8.3. Gene Therapy
9. Injections for SMA Market, by Route Of Administration
9.1. Introduction
9.2. Intrathecal Injection
9.3. Intravenous Injection
10. Injections for SMA Market, by Indication
10.1. Introduction
10.2. Type I
10.3. Type II
10.4. Type III
10.5. Type IV
11. Injections for SMA Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. Ambulatory Clinics
11.2.2. Specialty Clinics
11.3. Homecare Settings
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Injections for SMA Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.2.1. Contract Pharmacy
12.2.2. In-House Pharmacy
12.3. Retail Pharmacy
12.3.1. Chain Pharmacy
12.3.2. Independent Pharmacy
12.3.3. Online Pharmacy
12.4. Specialty Pharmacy
13. Americas Injections for SMA Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Injections for SMA Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Injections for SMA Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Biogen Inc.
16.3.2. Novartis Gene Therapies, Inc.
16.3.3. Ionis Pharmaceuticals, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. INJECTIONS FOR SMA MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INJECTIONS FOR SMA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC INJECTIONS FOR SMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC INJECTIONS FOR SMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. INJECTIONS FOR SMA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. INJECTIONS FOR SMA MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. INJECTIONS FOR SMA MARKET: RESEARCHAI
FIGURE 26. INJECTIONS FOR SMA MARKET: RESEARCHSTATISTICS
FIGURE 27. INJECTIONS FOR SMA MARKET: RESEARCHCONTACTS
FIGURE 28. INJECTIONS FOR SMA MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INJECTIONS FOR SMA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INJECTIONS FOR SMA MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INJECTIONS FOR SMA MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY INTRATHECAL INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY INTRATHECAL INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY TYPE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY TYPE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY TYPE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY TYPE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY TYPE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY TYPE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY TYPE IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY TYPE IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY CONTRACT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY CONTRACT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY IN-HOUSE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY IN-HOUSE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL INJECTIONS FOR SMA MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS INJECTIONS FOR SMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES INJECTIONS FOR SMA MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 114. CANADA INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 115. CANADA INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 116. CANADA INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 117. CANADA INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. CANADA INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. CANADA INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. CANADA INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. CANADA INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 122. CANADA INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 123. CANADA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 124. CANADA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 125. CANADA INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. CANADA INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. CANADA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. CANADA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. CANADA INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 130. CANADA INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 131. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 132. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 133. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 136. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 137. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 140. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 141. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 142. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 143. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 146. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 147. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 148. MEXICO INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA INJECTIONS FOR SMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 223. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 224. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 225. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 232. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 233. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 234. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 235. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 238. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 239. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. GERMANY INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 242. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 243. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 244. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 245. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 250. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 251. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 252. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 253. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 256. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 257. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. FRANCE INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 277. ITALY INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 278. ITALY INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 279. ITALY INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. ITALY INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. ITALY INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 282. ITALY INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 283. ITALY INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. ITALY INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. ITALY INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 286. ITALY INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 287. ITALY INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 288. ITALY INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 289. ITALY INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. ITALY INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. ITALY INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 292. ITALY INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 293. ITALY INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 294. ITALY INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 295. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 296. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 297. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 298. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 299. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 300. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 301. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 304. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 305. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 306. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 307. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 310. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 311. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 312. SPAIN INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES INJECTIONS FOR SMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 332. SAUDI ARABIA INJECTIONS FOR SMA MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 334. SAUDI ARABIA INJECTIONS FOR SMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 336. SAUDI ARABIA INJECTIONS FOR SMA MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA INJECTIONS FOR SMA MARKET SIZE, BY END USER, 2018-2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Injections for SMA market report include:
  • Biogen Inc.
  • Novartis Gene Therapies, Inc.
  • Ionis Pharmaceuticals, Inc.

Related Topics

Related Reports

Penpulimab Injection Market - Global Forecast 2025-2030 - Product Image

Penpulimab Injection Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Esketamine Hydrochloride Injection Market - Global Forecast 2025-2030 - Product Image

Esketamine Hydrochloride Injection Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Alferon N Injection Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Alferon N Injection Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From
Self-Injections Market Report 2025 - Product Image

Self-Injections Market Report 2025

  • Report
  • 200 Pages
  • Global
From
HIV Injections - Global Strategic Business Report - Product Image

HIV Injections - Global Strategic Business Report

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.